This task order is for determination of the in vitro inhibitory effect of experimental antibacterial substances in determinations against bacterial pathogens.
Ended Awarded Last action
- Contract number
- 75N93023F00002
- Awardee
-
Element Materials Technology Iowa City Inc. UEI GAJDDSFFPD89
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $106,000
Award facts
- Contract value 67% obligated
-
- $106,000.00 Current, with exercised options
- $159,000.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- North Liberty, IA 52317, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $26,500 | |
| Other Administrative Action | $0 | |
| Definitize Change Order | $0 | |
| Other Administrative Action | $0 | |
| Original award | $79,500 |
About this award
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $159,000 delivery order to Element Materials Technology Iowa City Inc., doing business as JMI Laboratories, for in vitro testing to determine the inhibitory effects of experimental antibacterial substances against bacterial pathogens. The contract, which was awarded on August 4, 2023, with an ultimate completion date of August 3, 2024, operates under a firm fixed-price structure with no small business set-aside designation. JMI Laboratories will perform this work at its facility in North Liberty, Iowa. This task order is issued under the In Vitro Assessments of Antimicrobial Activity (IVAAA) master contract vehicle, an indefinite-delivery/indefinite-quantity contract that NIAID utilizes for antimicrobial research support.
JMI Laboratories is a specialized microbiology firm that has provided extensive antimicrobial resistance testing and research services to federal agencies since 2016, with particular expertise in minimum inhibitory concentration assays and in vitro screening for antibacterial activity. The company regularly supports NIAID and other Department of Health and Human Services agencies in evaluating new antimicrobial compounds and studying emerging resistance trends. Under this delivery order, JMI Laboratories will contribute to NIAID's broader mission of addressing critical public health challenges related to antimicrobial resistance through systematic laboratory assessment of experimental antibacterial candidates.
Quick answers
Who was awarded contract 75N93023F00002?
75N93023F00002 was awarded to Element Materials Technology Iowa City Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 4, 2023.
How much is contract 75N93023F00002 worth?
The government has obligated $106,000 on 75N93023F00002. Its potential value, with all options, is $159,000.
Is contract 75N93023F00002 an order under another contract?
Yes. 75N93023F00002 is a delivery order under 75N93019D00011, an indefinite delivery contract, on In Vitro Assessments of Antimicrobial Activity (IVAAA).
Was contract 75N93023F00002 competed?
The extent of competition for 75N93023F00002 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award